19 results
Thumbnail

D2.545 - Perception of adult patients in an allergy clinic after using Scribe artificial intelligence, our experience

Thumbnail

D2.546 - Ethical Impact of Generative AI in Clinical Practice for Asthma and Allergy

Thumbnail

D2.547 - The Transparent and Credible AI for Clinical Protocols

Thumbnail

D2.548 - Expert Evaluation of Dialogue Quality and Clinical Reasoning in a Hybrid Multilingual LLM–Algorithm Allergy Decision-Support System: A Pilot Study of 34 Real-World Cases

Thumbnail

D3.51 - Cardiovascular System Problems in Children Athletes with Allergic Diseases

Thumbnail

D3.59 - Occupational Cobalt Contact Dermatitis: Clinical Profile and Work implications

Thumbnail

D3.52 - Clinical spectrum and diagnostic challenges of paediatric angioedema without wheals

Thumbnail

D3.55 - Hereditary angioedema with normal C1-INH: DAB2IP mutation report

Thumbnail

D3.56 - Investigation of Serum Eosinophilic Granule Proteins Levels in Children with Chronic Spontaneous Urticaria

Thumbnail

D3.58 - Eosinophilic ascites and extreme hypereosinophilia: differential diagnosis through medical treatment

Thumbnail

D3.60 - Allergic reaction in bisoprolol overdose

Thumbnail

D3.61 - Acquired Food Allergy After Allogeneic Hematopoietic Stem Cell Transplantation From a Non-Allergic Unrelated Donor

Thumbnail

D3.62 - Application of a logistic regression model to predict the risk of allergic reactions in children with salmon sensitization (Sal s 1)

Thumbnail

D3.50 - Molecular Characterization of Allergen Sensitization and Clinical Associations in a Romanian Cohort Using ALEX² Multiplex Assay

Thumbnail

D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region

Thumbnail

D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor

Thumbnail

D3.155 - Th2–Th17 immune shift following dupilumab therapy

Thumbnail

D3.160 - Study of the allergic sensitization profile in asthmatic patients consulting at ignace deen university hospital, conakry

Thumbnail

D3.164 - Early and Sustained Effect of Zumilokibart (APG777) in Atopic Dermatitis and Asthma: 16-Week Results from the Phase 2 APEX Study in Moderate-to-Severe AD and a Phase 1b Study in Mild-to-Moderate Asthma